AVICANNA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.49 CAD | +1.03% |
|
+28.95% | +40.00% |
| 07-11 | Avicanna Completes Commercial Export of Aureus Branded CBG Into Singapore | MT |
| 07-11 | Avicanna Brief: Subsidiary Completed Export of Aureus Branded CBG into Singapore | MT |
Presenter SpeechStephen Kim (Executives)Good morning. Welcome to the Annual Meeting of Shareho...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patientsâ needs and enhances the patient's journey.
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +40.00% | 35.94M | |
| +22.15% | 46.56B | |
| +45.94% | 41.67B | |
| -2.37% | 41.16B | |
| +33.84% | 32.4B | |
| -6.35% | 28.1B | |
| +20.42% | 28.18B | |
| +48.83% | 14.52B | |
| +45.00% | 13.74B | |
| +0.06% | 12.17B |
- Stock Market
- Equities
- AVCN Stock
- News Avicanna Inc.
- Transcript : Avicanna Inc. - Shareholder/Analyst Call
